T cell clonal anergy

Current Opinion in Immunology

Volumn 9, Issue 3, 1997, Pages 351-357

  Schwartz, Ronald H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; T LYMPHOCYTE RECEPTOR;

CLONAL ANERGY; GENETIC TRANSCRIPTION; ONCOGENE C FOS; ONCOGENE C JUN; REVIEW; T LYMPHOCYTE;

EID: 0030833571     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80081-7     Document Type: Article

References (44)

1. Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 165:1987;302-319.
2. Quill H, Schwartz RH. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferation nonresponsiveness. J Immunol. 138:1987;3704-3712.
3. Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH. Molecular events in the induction of a nonresponsive state in interleukin-2-producing helper T-lymphocyte clones. Proc Natl Acad Sci USA. 84:1987;5409-5413.
4. Beverly B, Kang S-M, Lenardo MJ, Schwartz RH. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int Immunol. 4:1992;661-671.
5. Mueller DL, Chiodetti L, Bacon PA, Schwartz RH. Clonal anergy blocks the response to IL-4, as well as the production of IL-2 in dual-producing helper T cell clones. J Immunol. 147:1991;4118-4125.
6. Kang S-M, Beverly B, Tran A-C, Bronson K, Schwartz RH, Lenardo MJ. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science. 257:1992;1134-1138.
7. Beverly B, Chiodetti L, Brorson K, Schwartz RH, Mueller DL. T cell anergy. Alt FW, Vogel HJ. Molecular Mechanisms of Immunological Self-Recognition. 1993;39-53 Academic Press, Inc, New York.
8. fyn. J Immunol. 149:1992;2887-2893.
9. Cho EA, Riley MP, Sillman AL, Quill H. Altered protein tyrosine phosphorylation in anergic Th1 cells. J Immunol. 151:1993;20-28.
10. + T cells. J Immunol. 151:1993;2355-2367.
11. Gajewski TF, Qian D, Fields P, Fitch FW. Anergic T lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc Natl Acad Sci USA. 91:1994;38-42.
12. + T cells. of outstanding interest Science. 271:1996;1272-1276 Shows that the activation of both the ERKs and JNKs is blocked in anergic T cells, whereas the calcium/calcineurin/NF-AT pathway is unaffected.
13. Mondino A, Whaley CD, DeSilva DR, Li W, Jenkins MK, Mueller DL. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, Fos B, and JunB in anergic T helper 1 cells. of outstanding interest J Immunol. 157:1996;2048-2057 Shows that anergy reduces the induction of c-Fos and JunB following TCR stimulation of T cell clones, whereas the calcium/calcineurin/NF-AT pathway is unaffected.
14. 2-terminal kinase and mitogen-activated protein kinase signaling pathways. J Exp Med. 183:1996;2017-2023.
15. ras upon T-cell activation. Nature. 346:1990;719-723.
16. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind JS, Spiegel S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381:1996;800-803.
17. ras activation is blocked in anergic T cell clones.
18. ras activation. J Exp Med. 177:1993;1221-1226.
19. Su B, Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol. 8:1996;402-411.
20. Jain J, Valge-Archer VE, Rao A. Analysis of the AP-1 sites in the IL-2 promoter. J Immunol. 148:1992;1240-1250.
21. Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, Bravo R, Kovary K, Leiden JM, Thompson CB. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol Cell Biol. 13:1993;1911-1919.
22. Chiu R, Angel P, Karin M. Jun-B differs in its biological properties from and is a negative regulator of c-Jun. Cell. 59:1989;979-986.
23. Ryseck RP, Bravo R. c-Jun, Jun B, and Jun D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene. 6:1991;533-542.
24. Coffer P, De Jonge M, Mettouchi A, Binetruy B, Ghysdael J, Kruijer W. jun-B promoter regulation: ras mediated transactivation by c-ETS-1 and c-ETS-2. Oncogene. 9:1994;911-921.
25. ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature. 351:1991;122-127.
26. Franklin CC, Sanchez V, Wagner F, Woodgett JR, Kraft AS. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation. Proc Natl Acad Sci USA. 89:1992;7247-7251.
27. Su B, Jacinto E, Hibi M, Kallunki T, Karin M, Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 77:1994;727-736.
28. Deng T, Karin M. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature. 371:1994;171-175.
29. Kitagawa-Sakakida S, Schwartz RH. Multifactor cis-dominant negative regulation of IL-2 gene expression in anergized T cells. of outstanding interest J Immunol. 157:1996;2328-2339 Documents the cis dominant-negative regulation of transcription of the IL-2 gene by AP-1-like proteins binding to the -150 and -180 sites in the enhancer.
30. Serfling E, Barthelmäs R, Pfeuffer I, Schenk B, Zarius S, Swoboda R, Mercurio F, Karin M. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J. 8:1989;465-473.
31. Garrity PA, Chen D, Rothenberg EV, Wold BJ. IL-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol Cell Biol. 14:1994;2159-2169.
32. Brunwand MW, Krumm A, Groudine M. In vivo footprinting of the human IL-2 gene reveals a nuclear factor bound to the transcription start site in T cells. Nucleic Acids Res. 21:1993;4824-4829.
33. Williams TM, Moolten D, Burlein J, Romano J, Bhaerman R, Godillot A, Mellon M, Rauscher FJ III, Kant JA. Identification of a zinc finger protein that inhibits IL-2 gene expression. Science. 254:1991;1791-1794.
34. Becker JC, Brabletz T, Kirchner T, Conrad CT, Bröcker E-B, Reisfeld RA. Negative transcriptional regulation in anergic T cells. of outstanding interest Proc Natl Acad Sci USA. 92:1995;2375-2378 The first description of negative regulation of transcription of the IL-2 gene in anergic T cells.
35. Genetta T, Ruezinsky D, Kadesch T. Displacement of an E-box-binding repressor by helix-loop-helix proteins: implications for B-cell specificity of the immunoglobulin heavy-chain enhancer. Mol Cell Biol. 14:1994;6153-6163.
36. Durand DB, Shaw JP, Bush MR, Replogle RE, Belageje R, Crabtree GR. Characterization of antigen receptor response elements within the interleukin 2 enhancer. Mol Cell Biol. 8:1988;1715-1724.
37. Ullman KS, Northrop JP, Admon A, Crabtree GR. Jun family members are controlled by a calcium-regulated, cyclosporin A-sensitive signaling pathway in activated T lymphocytes. Genes Dev. 7:1993;188-196.
38. Jain J, McCaffrey PG, Valge-Archer VE, Rao A. Nuclear factor of activated T cells contains Fos and Jun. Nature. 356:1992;801-804.
39. Rooney JW, Sun Y-L, Glimcher LH, Hoey T. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol. 15:1995;6299-6310.
40. Ghosh P, Tan T-H, Rice NR, Sica A, Young HA. The interleukin 2 CD28-responsive complex contains at least three members of the NFκB family: c-ReI, p50, and p65. Proc Natl Acad Sci USA. 90:1993;1696-1700.
41. Himes SR, Coles LS, Reeves R, Shannon MF. High mobility group protein I (Y) is required for function and c-ReI binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity. 5:1996;479-489.
42. Chen D, Rothenberg EV. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J Exp Med. 179:1994;931-942.
43. Briegel K, Hentsch B, Pfeuffer I, Serfling E. One base pair change abolishes the T cell-restricted activity of a κB-like proto-enhancer element from the interleukin 2 promoter. Nucleic Acids Res. 19:1991;5929-5936.
44. Serfling E, Avots A, Neumann M. The architecture of the interleukin-2 promoter: a reflection of the T lymphocyte activation. Biochim Biophys Acta. 1263:1995;181-200.